F Bonńici

1.2k total citations
33 papers, 627 citations indexed

About

F Bonńici is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, F Bonńici has authored 33 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in F Bonńici's work include Diabetes Management and Research (5 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers) and Lipoproteins and Cardiovascular Health (4 papers). F Bonńici is often cited by papers focused on Diabetes Management and Research (5 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers) and Lipoproteins and Cardiovascular Health (4 papers). F Bonńici collaborates with scholars based in South Africa, United States and Australia. F Bonńici's co-authors include Naomi Levitt, Deborah Bradshaw, Margaret Hoffman, Judith Katzenellenbogen, G M Berger, B. J. Cremin, Anette‐G. Ziegler, Roland Jimenez, Areti Philotheou and Markus Walter and has published in prestigious journals such as The Lancet, Diabetes Care and The American Journal of Medicine.

In The Last Decade

F Bonńici

29 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Bonńici South Africa 13 341 191 111 100 79 33 627
Isabel Salinas Spain 19 518 1.5× 286 1.5× 87 0.8× 82 0.8× 153 1.9× 43 921
A. C. Thai Singapore 15 333 1.0× 173 0.9× 208 1.9× 83 0.8× 67 0.8× 29 718
Päivi Kekäläinen Finland 14 259 0.8× 210 1.1× 167 1.5× 232 2.3× 104 1.3× 23 658
William C. Knowler United States 5 263 0.8× 97 0.5× 193 1.7× 124 1.2× 84 1.1× 6 773
Lydie Pani United States 8 302 0.9× 103 0.5× 108 1.0× 207 2.1× 60 0.8× 12 651
Anupama Ramachandran India 16 406 1.2× 297 1.6× 319 2.9× 81 0.8× 159 2.0× 45 876
Sutin Sriussadaporn Thailand 11 254 0.7× 91 0.5× 70 0.6× 79 0.8× 39 0.5× 43 467
Finney S. Geethanjali India 12 155 0.5× 141 0.7× 67 0.6× 42 0.4× 59 0.7× 17 463
Prakash Abraham United Kingdom 16 800 2.3× 121 0.6× 88 0.8× 120 1.2× 133 1.7× 31 1.1k
Dong Won Byun South Korea 15 275 0.8× 110 0.6× 81 0.7× 300 3.0× 50 0.6× 59 816

Countries citing papers authored by F Bonńici

Since Specialization
Citations

This map shows the geographic impact of F Bonńici's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Bonńici with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Bonńici more than expected).

Fields of papers citing papers by F Bonńici

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Bonńici. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Bonńici. The network helps show where F Bonńici may publish in the future.

Co-authorship network of co-authors of F Bonńici

This figure shows the co-authorship network connecting the top 25 collaborators of F Bonńici. A scholar is included among the top collaborators of F Bonńici based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Bonńici. F Bonńici is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leiter, Lawrence A., Hwee Teoh, Eugene Braunwald, et al.. (2015). Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial. Diabetes Care. 38(6). 1145–1153. 74 indexed citations
2.
Walter, Markus, et al.. (2009). No Effect of the Altered Peptide Ligand NBI-6024 on β-Cell Residual Function and Insulin Needs in New-Onset Type 1 Diabetes. Diabetes Care. 32(11). 2036–2040. 83 indexed citations
3.
Bonńici, F. (2004). Making insulin usage safer--the universal colour code.. PubMed. 94(5). 343–4.
4.
Bonńici, F, et al.. (2002). Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies. BMJ. 325(7363). 517–520. 32 indexed citations
5.
Zöllner, Ekkehard Werner, et al.. (2001). Fatal Liver Failure due to Ketoconazole Treatment of a Girl with Cushing's Syndrome. Journal of Pediatric Endocrinology and Metabolism. 14(3). 335–8. 15 indexed citations
6.
Pretorius, Carel, et al.. (1995). Two siblings with episodic ketoacidosis and decreased activity of succinyl‐CoA:3‐ketoacid CoA‐transferase in cultured fibroblasts. Journal of Inherited Metabolic Disease. 19(3). 296–300. 24 indexed citations
7.
Levitt, Naomi, Judith Katzenellenbogen, Deborah Bradshaw, Margaret Hoffman, & F Bonńici. (1993). The Prevalence and Identification of Risk Factors for NIDDM in Urban Africans in Cape Town, South Africa. Diabetes Care. 16(4). 601–607. 139 indexed citations
8.
Bonńici, F, et al.. (1991). Diencephalic syndrome with long-term survival.. PubMed. 37(7). 207–10. 5 indexed citations
9.
Steyn, Krisela, et al.. (1990). A six month trial of simvastatia im diabetic patients with hypercholesterolaemia. European Journal of Pharmacology. 183(3). 1016–1016. 1 indexed citations
10.
Bonńici, F, et al.. (1987). A bolus/basal multiple injection regimen in type I diabetes. A multicentre trial using a new 'fountain-pen' device for short-acting human insulin as well as long-acting human insulin.. PubMed. 71(12). 749–52. 6 indexed citations
11.
Bonńici, F, et al.. (1987). The effect of an intensive education programme on the glycaemic control of type I diabetic patients.. PubMed. 71(3). 164–6. 3 indexed citations
12.
Bonńici, F. (1983). Making the change to U-100 insulins. A patient education guide.. PubMed. 64(6). 201–3. 1 indexed citations
13.
Cremin, B. J., J Wiggelinkhuizen, & F Bonńici. (1982). Nephrocalcinosis in children. British Journal of Radiology. 55(654). 413–418. 23 indexed citations
14.
Huskisson, J, et al.. (1982). Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotype.. PubMed. 61(8). 266–72. 3 indexed citations
15.
Bonńici, F, et al.. (1980). Angiocardiographic and enzyme studies in a patient with type II glycogenosis (Pompe's disease). A case report.. PubMed. 58(21). 860–2. 3 indexed citations
16.
Bonńici, F. (1978). Functional hypoparathyroidism in infantile hypocalcaemic stage I vitamin D deficiency rickets.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 54(15). 611–2. 11 indexed citations
17.
Berger, G M, et al.. (1978). Continuous flow plasma exchange in the treatment of homozygous familial hypercholesterolemia. The American Journal of Medicine. 65(2). 243–251. 46 indexed citations
18.
Berger, G M & F Bonńici. (1977). Familial hyperchylomicronaemia in four families. Problems in diagnosis, management, and aetiology reviewed.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 51(18). 623–8. 11 indexed citations
19.
Emmett, Michael, et al.. (1977). THE ANION GAP. The Lancet. 309(8025). 1304–1305. 4 indexed citations
20.
Cywes, S., et al.. (1976). Portacaval shunt in two patients with homozygous type II hyperlipoproteinaemia.. PubMed. 50(8). 239–43. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026